Innocens
Antwerpen, Belgium
◆ Total Raised
$1.6M
◆ Stage
pre-seed
◆ Location
Antwerpen, Belgium
◆ Founded
2021
◆ Team size
1-10
◆ Links
◆ About Innocens
AI-powered digital assistant for monitoring premature babies and predicting life-threatening infections in neonatal care.
◆ What sets it apart
It combines explainable AI, real-time bedside risk prediction, and on-premise/hybrid-cloud deployment so clinicians stay in control of decisions.
◆ Sectors
◆ Business
ModelSaaS
CustomerHospitals and neonatal intensive care units (clinicians and healthcare providers)
◆ Notable
- Spin-off from University Hospital Antwerp and the University of Antwerp
- Won the EIT Health Wild Card Programme 2023
- Raised €1.5 million in funding
- Obtained ISO 13485:2016 certification scope for software as a medical device
◆ Backing funds on Raise
- Bharat Breakthrough Fund–Ipre-seed
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does Innocens do?
AI-powered digital assistant for monitoring premature babies and predicting life-threatening infections in neonatal care.
Where is Innocens based?
Innocens is based in Antwerpen, Belgium, founded in 2021.
How much has Innocens raised?
Innocens has raised $1.6M in tracked funding and is currently at the pre-seed stage.
Who has invested in Innocens?
Investors in Innocens include BAN Flanders, BeAngels, NXT-2, LRM, Qbic and existing shareholders.